Facebook Inc. took a momentous action last week. And I don’t mean its announced intention to sell shares for $28 to $35 in an initial public offering later this month.

China is proposing forward-thinking transplant policies that offer to pay organ donors. These proposals challenge the status quo, however if China is serious about creating an incentive program, transparency and accountability will be vital to its integrity and safety.

Sally Satel M.D., author of When Altruism Isn't Enough: The Case for Compensating Kidney Donors, will be available for comment.

Informed, willing and healthy prisoners should not be deprived of the opportunity to help the sick while improving their own prospects once they are free.

Israel should be commended for its two-pronged approach to its organ problem: incentives and efforts to combat trafficking.

As ingenious, painstaking and justifiably attention-getting as domino swaps are, they should not blot out the dismal news that rates of kidney donation, from both living and deceased donors, fall woefully short of the need.

The public is receptive to the idea of rewarding organ donors. It's time to leverage that receptivity.

Please note: This event has been canceled. At this event, Sally Satel, M.D., will discuss her new book, When Altruism Isn’t Enough: The Case for Compensating Kidney Donors and the national organ shortage.